Moyamoya-Disease-Information-Page

Moyamoya-Disease-Information-Page

Moyamoya Disease Information Page

What research is being done?

The NINDS conducts and supports neurological research aimed at understanding why diseases develop in the brain, in order to find ways to prevent, treat, or cure them. Anti-angiogenic therapy uses drugs that either activate and promote cell growth or directly block the growing blood vessel cells.  NINDS-funded researchers are testing the anti-angiogenic drug Apo-Timop, part of a class of drugs called beta-blockers, which may lead to the development of new anti-angiogenics for people with vascular malformations. In other research, Other NINDS-funded research hopes to improve the understanding of this disease by determining whether infections injure blood vessels and thereby predispose children to stroke. It will also determine causes of recurrence, a crucial step toward developing ways to prevent repeated strokes in children.

Information from the National Library of Medicine’s MedlinePlus
Genetic Brain Disorders
Vascular Diseases

×
What research is being done?

The NINDS conducts and supports neurological research aimed at understanding why diseases develop in the brain, in order to find ways to prevent, treat, or cure them. Anti-angiogenic therapy uses drugs that either activate and promote cell growth or directly block the growing blood vessel cells.  NINDS-funded researchers are testing the anti-angiogenic drug Apo-Timop, part of a class of drugs called beta-blockers, which may lead to the development of new anti-angiogenics for people with vascular malformations. In other research, Other NINDS-funded research hopes to improve the understanding of this disease by determining whether infections injure blood vessels and thereby predispose children to stroke. It will also determine causes of recurrence, a crucial step toward developing ways to prevent repeated strokes in children.

Information from the National Library of Medicine’s MedlinePlus
Genetic Brain Disorders
Vascular Diseases

The NINDS conducts and supports neurological research aimed at understanding why diseases develop in the brain, in order to find ways to prevent, treat, or cure them. Anti-angiogenic therapy uses drugs that either activate and promote cell growth or directly block the growing blood vessel cells.  NINDS-funded researchers are testing the anti-angiogenic drug Apo-Timop, part of a class of drugs called beta-blockers, which may lead to the development of new anti-angiogenics for people with vascular malformations. In other research, Other NINDS-funded research hopes to improve the understanding of this disease by determining whether infections injure blood vessels and thereby predispose children to stroke. It will also determine causes of recurrence, a crucial step toward developing ways to prevent repeated strokes in children.

Information from the National Library of Medicine’s MedlinePlus
Genetic Brain Disorders
Vascular Diseases


Definition
Definition
Treatment
Treatment
Prognosis
Prognosis
Clinical Trials
Clinical Trials
Organizations
Organizations
Publications
Publications

An informational booklet about stroke compiled by the National Institute of Neurological Disorders and Stroke (NINDS).

Stroke information sheet compiled by the National Institute of Neurological Disorders and Stroke (NINDS).

Multi-infarct dementia information sheet compiled by the National Institute of Neurological Disorders and Stroke (NINDS).

Cerebral arteriosclerosis information sheet compiled by the National Institute of Neurological Disorders and Stroke (NINDS).